Latest Interest Expense News

Autosports Group reports a 22% jump in order write driven by battery electric vehicles, with FY26 profit forecast raised to $51-54 million.

Mesoblast has drawn US$50 million from a new five-year facility that reduces its interest burden and retires expensive short-term debt, strengthening its financial position ahead of commercial expansion.

IFM Global Infrastructure Fund has increased its holding in Atlas Arteria to over 40%, maintaining a final takeover offer of A$5.10 per security. Meanwhile, Atlas Arteria's independent directors continue to recommend rejecting the bid, targeting higher distributions and exploring asset sales including the Warnow Tunnel.

Metro Performance Glass has significantly improved its financial footing in FY26, cutting net debt by more than half and boosting EBITDA before significant items to $18.2 million despite subdued markets in New Zealand and Australia.

Gumtree Australia Markets has refinanced its Commonwealth Bank loan, cutting quarterly repayments and extending the facility to November 2027, freeing up cashflow to support sales growth.

Dalrymple Bay Infrastructure Limited (DBI) forecasts an 8.1% increase in terminal infrastructure charges for TY-26/27, alongside an 8.5% uplift in distribution guidance, reflecting strong operational performance and ongoing capital investment.

SPC Global Holdings has kicked off a fully underwritten $100 million equity raise via a 1-for-0.1993 renounceable entitlement offer priced at $0.10 per share, aiming to sharply reduce net debt and back its expansion plans.

Sanford Limited delivered record half-year earnings despite a 5.5% revenue dip, driven by robust salmon and wildcatch segments, while mussel farming faced headwinds. The company cut net debt by NZ$63 million and declared a steady 5.0 cps dividend.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

SPC Global Holdings (ASX: SPG) has voluntarily suspended trading of its shares pending details of a proposed equity raising, with the suspension expected to last until 11 May or until the announcement is made.

Synlait Milk has obtained waivers from its syndicated banks on key financial covenants for the quarter ending April 2026, reflecting ongoing operational and market challenges.

ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.